Board of Directors
Chair of the Board
A pharma industry leader and entrepreneur with a focus on driving improvements in clinical trial execution, at scale, through innovative solutions. In 1999, she founded The Avoca Group, whose Avoca Quality Consortium paved the way for Diligent Pharma and the Diligent
Todd Johnson, MBA
Partner with FCA Venture Partners. 20+ years as a leader in early-stage healthcare companies, including the founding of HealthTech Corp, where he also served as CEO. Todd later co-founded and was a Managing Partner for KeraNetics.
Tom Hearn, MPH, MBA
30+ years as a healthcare leader, with experience serving as Senior Vice President of Ambulatory Services for Novant Health, Inc., Chief Development Officer of MedCath, Inc. and CEO of MedCath Partners, LLC. Tom also co-founded and served as President of Decision Support Systems and was VP of Administration at Atrium Health.
An investment expert, David is the Managing Partner and a co-founder of PJC, a venture capital firm. With extensive experience investing broadly in B2B SaaS, Consumer and Tech Enabled Service companies, he currently sits on the Board of Trustees at the University of Rhode Island and the Investment Committee of Lifespan.